MOA Between IUKL & BioGenes Technologies Sdn. Bhd. for MOSTI R&D Grant Award

/ / Published in Campus News

It is with great pleasure that we announce that IUKL and BioGenes Technologies Sdn. Bhd. have been awarded a RM 1.13 million Research & Development grant by the Ministry of Science, Technology & Innovation (MOSTI), Malaysia to jointly develop Point-of-Care testing (POCT) biosensor system using next-generation detection technology for the surveillance and control of Food & Mouth virus and other important veterinary infectious diseases.

BioGenes Technologies Sdn. Bhd., a biotech company specialising in biosensors will be commercialising a patent-pending technology that produces functional “synthetic antibodies” or aptamers under a licensing agreement from Dr. Samson Soon from the Faculty of Engineering, Science & Technology, IUKL in its electrochemical-based aptasensor for the rapid detection of infectious pathogens. Aptasensor technology integrates the application of aptamer nanomaterial and digital sensors to identify a target biomolecule or pathogen. The technology platform provides a next-generation digital rapid Point-of-Care testing (POCT) system that can detect the presence of live pathogens through real-time biosensing in active surveillance operations without the need for expensive equipment and chemistries.

Official Memorandum of Agreement (MoA) signing ceremony between IUKL and BioGenes Technologies Sdn. Bhd. From left Assoc. Prof. Dr. Kong Wei, Deputy Vice-Chancellor IUKL, Prof. Dr. Ideris Zakaria, President & Vice-Chancellor IUKL, Mr. Tang Kok Mun, CEO, BioGenes Technologies Sdn. Bhd., Mr. Cheng Kim Sing, Director, BioGenes Technologies Sdn. Bhd.
Official Memorandum of Agreement (MoA) signing ceremony between IUKL and BioGenes Technologies Sdn. Bhd. From left Assoc. Prof. Dr. Kong Wei, Deputy Vice-Chancellor IUKL, Prof. Dr. Ideris Zakaria, President & Vice-Chancellor IUKL, Mr. Tang Kok Mun, CEO, BioGenes Technologies Sdn. Bhd., Mr. Cheng Kim Sing, Director, BioGenes Technologies Sdn. Bhd.